Title |
Disease/Condition |
Principal Investigator |
5-Cog Battery to Improve Detection of Cognitive Impairment and Dementia (5-COG)
|
Mental Health and Disorders,Brain and Neurological,Neurology,Geriatrics,Alzheimer's Disease,Dementia
|
Joe Verghese, MD
|
A 12-Month, Open-Label, Repeat-Dose Safety Study of NRL-1 in Epilepsy Subjects
|
Brain and Neurological,Neurology,Epilepsy,Seizures
|
Alexis Boro, MD
|
A 24 Week, Multicenter, Randomized, Double-Blind, Parallel Group, Phase 3 Trial with a 28 Week Long Term Safety Extension Period Evaluating the Safety and Efficacy of Dapagliflozin 10 mg in T2DM Patients aged 10-24 years.
|
Pediatric Endocrinology
|
Rubina Heptulla
|
A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease (TARGET-IBD)
|
Gastroenterology & Liver Diseases,Inflammatory Bowel Disease,Colitis and Crohn's Disease
|
Gitit Tomer, MD
|
A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)
|
Liver Diseases,Gastroenterology & Liver Diseases
|
Bryan Rudolph, MD
|
A Combination Study of PF-04449913 (Glasdegib) and Azacitidine In Untreated MDS, AML and CMML Patients (BRIGHT 1012)
|
Myelodysplastic Syndrome (MDS),Hematologic Diseases,Oncology (Medical/Hematologic),Leukemia,Neoplasms
|
Amit Verma, MD
|
A Double-Blind Efficacy and Safety Study of the Phosphodiesterase Type 5 Inhibitor Tadalafil in Pediatric Patients with Pulmonary Arterial Hypertension
|
Pediatrics
|
Nicole Sutton
|
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Omecamtiv Mecarbil on Mortality and Morbidity in Subjects With Chronic Heart Failure With Reduced Ejection Fraction (GALACTIC-HF)
|
Heart and Vascular Diseases,Cardiology,Geriatrics,Heart Failure
|
Jooyoung Julia Shin, MD
|
A Feasibility and Biomarker Study to Evaluate Necitumumab in the Neoadjuvant Setting With Gemcitabine and Cisplatin in Surgically Resectable Squamous Lung Cancer
|
Lung Cancer,Oncology (Medical/Hematologic),Lung Diseases,Neoplasms
|
Balazs Halmos, MD
|
A Long-Term, Open-Label Follow-up Study of Tofacitinib for Treatment of Juvenile Idiopathic Arthritis (JIA)
|
Rheumatic Diseases,Pediatrics,Arthritis,Musculoskeletal Diseases,Autoimmune Diseases
|
Dawn Wahezi, MD
|
A multi-center prospective study to evaluate the safety and effectiveness of the VasQ external support for arteriovenous fistula
|
Diabetes and Endocrine,Kidney Diseases (incl Chronic Kidney Disease),Surgery,Cardiovascular and Thoracic Surgery,Urologic Diseases,Geriatrics,Metabolic Diseases,Aneurysm
|
Stuart Greenstein, MD
|
A Multi-center, Randomized Controlled Study of the Vertos MILD Procedure With Conventional Medical Management Versus Conventional Medical Management Alone in the Treatment of Lumbar Spinal Stenosis (The MOTION Study)
|
Bones, Muscles & Joints (Orthopaedics),Rehabilitation Medicine,Geriatrics,Musculoskeletal Diseases,Spinal Cord Diseases
|
Sayed Wahezi, MD
|
A Multi-Center, Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Phase 3 Study With Randomized Withdrawal and Retreatment to Evaluate the Efficacy and Safety of BMS-986165 in Subjects With Moderate-to-Severe Plaque Psoriasis
|
Skin Disorders,Dermatology,Psoriasis
|
Holly Kanavy, MD
|
A Multi-Center, Randomized, Placebo Controlled, Double-Blind Study to Confirm Efficacy and Safety of Terlipressin in Subjects With Hepatorenal Syndrome Type 1 (The CONFIRM Study)
|
Kidney Diseases (incl Chronic Kidney Disease),Liver Diseases,Gastroenterology & Liver Diseases,Urologic Diseases,Geriatrics
|
Samuel Sigal, MD
|
A Multi-center, Randomized, Placebo-controlled, Double-blind, Adaptive Clinical Trial of Vitamin C, Thiamine and Steroids as Combination Therapy in Patients With Sepsis
|
Critical Care,Infectious Diseases,Sepsis,Systematic Inflammatory Response Syndrome (SIRS)
|
Michelle Gong, MD
|
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients With Hematologic Malignancies and Other Indications
|
Blood Disorders and Diseases,Hematologic Diseases,Oncology (Medical/Hematologic),Pediatric Hematology/Oncology,Leukemia,Non-Hodgkins Lymphoma,Lymphoma,Neoplasms,Anemia,Lymphoproliferative Disorders,Immune System Diseases
|
David Loeb, MD
|
A Multicenter Safety Study of Unlicensed, Investigational Cryopreserved Cord Blood Units Manufactured by the National Cord Blood Program and Provided for Unrelated Hematopoietic Stem Cell Transplantation of Pediatric and Adult Patients
|
Blood and Bone Marrow Cancer,Blood Disorders and Diseases
|
David Loeb, MD
|
A Multicenter, Double-Blind, Parallel-Arm, Placebo-Controlled, Phase 2 Study of the Efficacy, Safety, and Tolerability of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrence of Clostridium Difficile Infection (PRISM 3)
|
Infectious Diseases
|
Paul Riska, MD
|
A Multicenter, Open-Label, Phase 1B/2 Study to Evaluate Safety and Efficacy of Avelumab (MSB0010718C) IN COMBINATION WITH Chemotherapy With Or Without Other Anti-Cancer Immunotherapies as First-Line Treatment In Patients With Advanced Malignancies
|
Lung Cancer,Oncology (Medical/Hematologic),Lung Diseases,Carcinoma,Neoplasms
|
Balazs Halmos, MD
|
A Multicenter, Open-label, Randomized, Event-driven Study to Assess Efficacy, Safety and Pharmacokinetics of Macitentan Versus Standard of Care in Children With Pulmonary Arterial Hypertension (PAH) (TOMORROW)
|
Heart and Vascular Diseases,Pediatrics,Pulmonary Hypertension,Lung Diseases
|
Nicole Sutton, MD
|
A Multicenter, Open-label, Randomized, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib in Combination With Everolimus or Pembrolizumab Versus Sunitinib Alone in First-Line Treatment of Subjects With Advanced Renal Cell Carcinoma (CLEAR)
|
Kidney Diseases (incl Chronic Kidney Disease),Kidney Cancer,Oncology (Medical/Hematologic),Urologic Oncology (Med Onc),Urologic Diseases,Carcinoma,Urogenital Neoplasms
|
Benjamin Gartrell, MD
|
A Multicenter, Prospective, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study of BB3 to Reduce the Severity of Delayed Graft Function in Recipients of a Deceased Donor Kidney
|
Kidney Diseases (incl Chronic Kidney Disease)
|
Enver Akalin, MD
|
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Elafibranor in Patients with Nonalcoholic Steatohepatitis (NASH) and fibrosis.
|
Liver Diseases,Gastroenterology & Liver Diseases,Fibrosis
|
Samuel Sigal, MD
|
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
|
Gastroenterology & Liver Diseases,General Internal Medicine,Geriatrics,Inflammatory Bowel Disease,Colitis and Crohn's Disease
|
Joann Kwah, MD
|
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Operationally Seamless, Adaptive Phase 2/3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata
|
Skin Disorders,Dermatology
|
Steven Cohen, MD
|
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Ustekinumab in Subjects With Active Systemic Lupus Erythematosus
|
Rheumatic Diseases,Dermatology,Pediatrics,Geriatrics,Lupus,Autoimmune Diseases
|
Chaim Putterman, MD
|
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-022, an Anti-TIM-3 Monoclonal Antibody, in Patients With Advanced Solid Tumors (AMBER)
|
Colon, Colorectal and Rectal Cancer,Lung Cancer,Solid Tumor,Metastatic Cancer,Oncology (Medical/Hematologic),Neoplasms
|
Sanjay Goel, MD
|
A Phase 1 Dose-ranging Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MRG-106 Following Local Intratumoral, Subcutaneous, and Intravenous Administration in Subjects With Various Lymphomas and Leukemias
|
Oncology (Medical/Hematologic),Leukemia,Non-Hodgkins Lymphoma,Lymphoma,Lymphatic and Spleen Diseases,Neoplasms,Lymphoproliferative Disorders,Immune System Diseases
|
Noah Kornblum, MD
|
A Phase 1, Open-Label, Non-Randomized, Safety, Tolerability and Pharmacokinetic Study of TAS3681 in Patients With Metastatic Castration Resistant Prostate Cancer
|
Prostate Cancer,Oncology (Medical/Hematologic),Urogenital Neoplasms
|
Benjamin Gartrell, MD
|
A Phase 1-2 Multi-Center Study Evaluating KTE-C19 in Subjects With Refractory Aggressive Non-Hodgkin Lymphoma (ZUMA-1) (ZUMA-1)
|
Blood and Bone Marrow Cancer
|
Ira Braunschweig, MD
|
A Phase 1/1b Study of MGCD516 in Patients With Advanced Solid Tumor Malignancies
|
Head and Neck Cancer,Lung Cancer,Prostate Cancer,Solid Tumor,Kidney Cancer,Carcinoma,Neoplasms
|
Sanjay Goel, MD
|
A Phase 1b Dose-Escalation Study of Cabozantinib (XL184) Administered Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
|
Colon, Colorectal and Rectal Cancer,Gastrointestinal Cancer,Head and Neck Cancer,Lung Cancer,Prostate Cancer,Solid Tumor,Thyroid Cancer,Kidney Cancer,Metastatic Cancer,Oncology (Medical/Hematologic),Carcinoma
|
Sanjay Goel, MD
|
A Phase 1b Study to Assess the Safety, Tolerability, and Clinical Activity of BGB-290 in Combination with Temozolomide (TMZ) in Subjects with Locally Advanced or Metastatic Solid Tumors
|
Breast Cancer,Gastrointestinal Cancer,Lung Cancer,Prostate Cancer,Solid Tumor,Oncology (Medical/Hematologic),Cancer,Neoplasms
|
Sanjay Goel, MD
|
A Phase 1b/2, Open-Label, Dose Escalation Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of SM88 in Patients With Prostate Cancer
|
Prostate Cancer,Oncology (Medical/Hematologic),Urologic Oncology (Med Onc),Neoplasms,Urogenital Neoplasms
|
Benjamin Gartrell, MD
|
A Phase 1b/2a, Multi-Center Open-Label Study to Evaluate the Safety and Efficacy of Combination Treatment With MEDI0457 (INO-3112) and Durvalumab (MEDI4736) in Patients With Recurrent/Metastatic HPV Associated Head and Neck Squamous Cancer
|
Head and Neck Cancer,Medical and Hematologic Oncology,Oncology (Medical/Hematologic),Human Papilloma Virus (HPV),Neoplasms
|
Balazs Halmos, MD
|
A Phase 2 Open-Label, Randomized Study of PARP Inhibition (Olaparib) Either Alone or in Combination With Anti-PD-L1 Therapy (Atezolizumab; MPDL3280A) in Homologous DNA Repair (HDR) Deficient, Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
|
Breast Cancer,Oncology (Medical/Hematologic),Neoplasms
|
Jesus Anampa Mesias, MD
|
A Phase 2 Study of Poziotinib in Patients With Non-Small Cell Lung Cancer (NSCLC), Locally Advanced or Metastatic, With EGFR or HER2 Exon 20 Insertion Mutation (ZENITH20)
|
Lung Cancer,Metastatic Cancer,Genetic Disorders,Oncology (Medical/Hematologic)
|
Haiying Cheng, MD
|
A Phase 2 Study of the Safety, Tolerability, and Efficacy of Parsaclisib in Combination With Ruxolitinib in Subjects With Myelofibrosis
|
Blood and Bone Marrow Cancer,Blood Disorders and Diseases,Hematologic Diseases,Medical and Hematologic Oncology,Oncology (Medical/Hematologic),Cancer,Myelofibrosis
|
Swati Goel, MD
|
A Phase 2, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of an Anti-OX40 Monoclonal Antibody (KHK4083) in Subjects With Moderate to Severe Atopic Dermatitis (AD)
|
Skin Disorders,Genetic Disorders,Dermatology,Immune System Diseases
|
Holly Kanavy, MD
|
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess Safety and Efficacy of Topically-applied AG013 for the Attenuation of Oral Mucositis in Subjects w/Cancers of Head and Neck Receiving Concomitant Chemoradiation Therapy
|
Head and Neck Cancer,Gastroenterology & Liver Diseases,Oral Mucositis
|
Madhur Garg, MD
|
A Phase 2, Open-Label Study of Parsaclisib in Participants With Autoimmune Hemolytic Anemia
|
Hematologic Diseases,Autoimmune Diseases,Anemia,Immune System Diseases
|
Irina Murakhovskaya, MD
|
A Phase 2, Randomized, Double-Blind, Dose-Ranging Study to Determine the Pharmacokinetics, Safety and Tolerability of Vedolizumab IV in Pediatric Subjects With Ulcerative Colitis or Crohn's Disease
|
Gastroenterology & Liver Diseases,Pediatrics,Inflammatory Bowel Disease,Colitis and Crohn's Disease
|
John Thompson, MD
|
A Phase 2b/3 Prospective, Randomized, Double-Blind, Sham-Controlled Trial of VTS-270 (2-hydroxypropyl---cyclodextrin) in Subjects with Neurologic Manifestations of Niemann-Pick Type C1 (NPC1) Disease
|
Genetics
|
Paul Levy
|
A Phase 3 Randomized Study Comparing Perioperative Nivolumab vs. Observation in Patients With Localized Renal Cell Carcinoma Undergoing Nephrectomy (PROSPER RCC)
|
Kidney Diseases (incl Chronic Kidney Disease),Lung Cancer,Skin Disorders,Kidney Cancer,Oncology (Medical/Hematologic),Urologic Oncology (Med Onc),Urologic Diseases,Lung Diseases,Carcinoma,Neoplasms,Urogenital Neoplasms
|
Benjamin Gartrell, MD
|
A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Patients w/Influenza A Infection
|
Infectious Diseases,Pediatrics,Geriatrics,Influenza
|
Paul Riska, MD
|
A Phase 3 Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Upadacitinib in Adolescent and Adult Subjects With Moderate to Severe Atopic Dermatitis
|
Skin Disorders,Dermatology,Pediatrics,Geriatrics,Immune System Diseases
|
Holly Kanavy, MD
|
A Phase 3 Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer
|
Prostate Cancer,Oncology (Medical/Hematologic),Neoplasms,Urogenital Neoplasms
|
Benjamin Gartrell, MD
|
A Phase 3 Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Subjects With Advanced Urothelial Cancer and Selected FGFR Gene Aberrations
|
Bladder Cancer,Genetic Disorders,Oncology (Medical/Hematologic),Urologic Oncology (Med Onc),Urologic Diseases,Geriatrics,Urogenital Neoplasms
|
Benjamin Gartrell, MD
|
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
|
Liver Diseases,Gastroenterology & Liver Diseases
|
Samuel Sigal, MD
|
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (REVERSE)
|
Liver Diseases,Gastroenterology & Liver Diseases,Fibrosis
|
Samuel Sigal, MD
|
A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects With Acute Coronary Syndrome
|
Heart and Vascular Diseases,Cardiology,Radiology
|
Anna Bortnick, MD
|
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Oral RPC1063 as Induction and Maintenance Therapy for Moderate to Severe Ulcerative Colitis
|
Gastroenterology & Liver Diseases,Geriatrics,Colitis and Crohn's Disease
|
Thomas Ullman, MD
|
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migraine (Advance)
|
Brain and Neurological,Headache,Migraine,Nervous System Diseases
|
Richard Bruce Lipton, MD
|
A Phase 3, Randomized, Adaptive Study Comparing the Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients Undergoing Hematopoietic Stem Cell Transplant
|
Pediatric Hematology/Oncology
|
Deepa Manwani
|
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Sutimlimab in Patients With Primary Cold Agglutinin Disease Without a Recent History of Blood Transfusion (Cadenza Study)
|
Hematologic Diseases,Autoimmune Diseases,Anemia,Immune System Diseases
|
Irina Murakhovskaya, MD
|
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
|
Pediatric Endocrinology
|
Rubina Heptulla
|
A Phase 3, Randomized, Multicenter, Single-blind, Controlled Study Evaluating Arteriovenous Fistula Outcomes With and Without a Perivascular Sirolimus-Eluting Collagen Implant
|
Kidney Diseases (incl Chronic Kidney Disease),Heart and Vascular Diseases,Cardiology,Cardiovascular and Thoracic Surgery,Urologic Diseases
|
Larry Scher, MD
|
A Phase 3, Randomized, Open-Label, Multicenter Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
|
Kidney Diseases (incl Chronic Kidney Disease),Hematologic Diseases,Nephrology,Pediatrics,Urologic Diseases,Metabolic Diseases
|
Anna Zolotnitskaya, MD
|
A Phase I-II Study of PTX-200 Plus Sequential Weekly Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide in Patients With Metastatic and Locally Advanced Breast Cancer
|
Breast Cancer,Women`s Health,Oncology (Medical/Hematologic),Carcinoma,Neoplasms
|
Joseph Sparano, MD
|
A Phase I/II Dose Escalation and Expansion Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK525762 in Combination With Fulvestrant in Subjects With HR+/HER2- Advanced or Metastatic Breast Cancer
|
Breast Cancer,Skin Disorders,Medical and Hematologic Oncology,Neoplasms
|
Sun Young Oh, MD
|
A Phase I/IIa, Open Label, Dose-escalation Study Investigating the Safety, Tolerability, and Pharmacokinetics of Intravenous Liposomal Vinorelbine Tartrate Injection in Patients With Advanced Malignancy
|
Oncology (Medical/Hematologic),Lymphoma,Neoplasms
|
Sanjay Goel, MD
|
A Phase II Multi-Center, Randomized, Double-Blind, 24-Week, Parallel Group, Placebo-Controlled Study to Investigate the Efficacy and Safety of Balovaptan (RO5285119) in Children and Adolescents Age 5-17 With Autism Spectrum Disorder (ASD)
|
Mental Health and Disorders,Autism Spectrum Disorder,Pediatrics,Psychiatry - Non Cancer,Neurodevelopmental Disorders
|
Eric Hollander, MD
|
A Phase II Randomized, Double-Blind, Placebo-Controlled Multi-Center Study to Assess the Safety, Tolerability, and Efficacy of Riociguat in Patients With Sickle Cell Diseases
|
Blood Disorders and Diseases,Hematologic Diseases,Sickle Cell,Anemia
|
Caterina Minniti, MD
|
A Phase II Study of MLN0128 (TAK-228) in Rapalog-Resistant Advanced Pancreatic Neuroendocrine Tumors (PNET)
|
Pancreatic Cancer,Solid Tumor,Metastatic Cancer,Oncology (Medical/Hematologic),Carcinoma,Neoplasms
|
Lakshmi Rajdev, MD
|
A Phase II Trial Assessing the Tolerability of Palbociclib in Combination With Letrozole or Fulvestrant in Patients Aged 70 and Older With Estrogen Receptor-Positive, HER2-Negative Metastatic Breast Cancer
|
Breast Cancer,Women`s Health,Oncology (Medical/Hematologic),Neoplasms
|
Jesus Anampa Mesias, MD
|
A Phase II, Randomized, Multi-Center, Double-Blind, Comparative Global Study to Determine Efficacy and Safety of Durvalumab in Combination With Olaparib for First-Line Treatment in Platinum-Ineligible Patients with Unresectable Stage IV Urothelial Cancer
|
Bladder Cancer,Oncology (Medical/Hematologic),Urologic Oncology (Med Onc),Urologic Diseases,Geriatrics,Neoplasms,Urogenital Neoplasms
|
Benjamin Gartrell, MD
|
A Phase III Study for Patients With Newly Diagnosed Acute Promyelocytic Leukemia (APL) Using Arsenic Trioxide and All-Trans Retinoic Acid
|
Pancreatic Cancer,Oncology (Medical/Hematologic),Pediatric Hematology/Oncology,Leukemia,Neoplasms
|
Lisa Gennarini, MD
|
A Phase WW Study of Human-Mouse Chimeric Anti-Disialoganglioside Monoclonal Antibody Ch14.18 (Dinutuximab, NSC764038, IND 4308) in Combination with Sargramostim (GM-CSF) in Patients with Recurrent Osteosarcoma.
|
Pediatric Hematology/Oncology
|
Lisa Figueiredo
|
A Pilot Presurgical Trial of Insulin Inhibition by a Ketogenic Diet in Operable Breast Cancer
|
Breast Cancer,Women`s Health,Oncology (Medical/Hematologic),Neoplasms
|
Eugene Fine, MD
|
A Pilot Study to Assess the Role of Cannabis Added to the Supportive Care Regimen During Chemoradiation for Head and Neck Cancer
|
Head and Neck Cancer,Radiation Oncology,Neoplasms
|
Rafi Kabarriti, MD
|
A Prospective Clinical Evaluation of the DiamondTemp™ System for the Treatment of Persistent Atrial Fibrillation
|
Heart and Vascular Diseases,Cardiology,Neurology
|
Luigi Di Biase, MD, PhD
|
A Prospective Investigation of the Risks of Opioid Misuse, Abuse, and Addiction Among Patients Treated With Extended-release/Long Acting (ER/LA) Opioids for the Treatment of Chronic Pain
|
Addiction,General Internal Medicine,Geriatrics
|
Joanna Starrels, MD
|
A Prospective Observational Study of Adult Patients Receiving DUPIXENT® for Atopic Dermatitis
|
Skin Disorders,Genetic Disorders,Dermatology
|
Holly Kanavy, MD
|
A Prospective, Observational, Non-Interventional, Post-Marketing, Patient Registry to Collect Data on Routine Clinical Care in Patients Treated With Cholbam®/Kolbam® (Cholic Acid)
|
Liver Diseases,Gastroenterology & Liver Diseases,Pediatrics
|
Nadia Ovchinsky, MD
|
A Randomized Phase II Clinical Trial Assessing the Efficacy and Safety of MK-3475 (Pembrolizumab) in Combination With Carboplatin and Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer
|
Breast Cancer,Women`s Health,Oncology (Medical/Hematologic),Neoplasms
|
Sun Young Oh, MD
|
A Randomized Phase II Study Comparing Single-Agent Olaparib, Single Agent Cediranib, and the Combination of Cediranib/Olaparib in Women With Recurrent, Persistent or Metastatic Endometrial Cancer
|
Obstetrics & Gynecology and Women`s Health,Urologic Oncology (Med Onc),Cancer,Carcinoma,Urogenital Neoplasms
|
Nicole Nevadunsky, MD
|
A Randomized Phase II Study of Nivolumab After Combined Modality Therapy (CMT) in High Risk Anal Cancer
|
Gastrointestinal Cancer,Anal Cancer,Gastroenterology & Liver Diseases,Radiation Oncology,Carcinoma,Neoplasms
|
Rafi Kabarriti, MD
|
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
|
Breast Cancer,Women`s Health,Skin Disorders,Medical and Hematologic Oncology,Neoplasms
|
Della Makower, MD
|
A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
|
Breast Cancer,Skin Disorders,Radiation Oncology,Neoplasms
|
Jana Fox, MD
|
A Randomized Placebo Controlled Trial of IV Metoclopramide for Acute Post-traumatic Headache
|
Brain and Neurological,Headache,Nervous System Diseases,Pain Management
|
Benjamin Friedman, MD
|
A Randomized, Crossover Phase 1 Study to Evaluate the Effects of Pevonedistat on the QTc Interval in Patients With Advanced Solid Tumors
|
Solid Tumor,Metastatic Cancer,Oncology (Medical/Hematologic)
|
Sanjay Goel, MD
|
A Randomized, Double-Blind, Placebo-Controlled Dose Ranging Study Evaluating Safety, Pharmacokinetics and Clinical Benefit of FLU-IGIV in Hospitalized Patients With Serious Influenza A Infection
|
Infectious Diseases,Lung Diseases,Influenza
|
Paul Riska, MD
|
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Subjects With Extensive Stage Small Cell Lung Cancer (MERU)
|
Lung Cancer,Oncology (Medical/Hematologic),Lung Diseases,Carcinoma,Neoplasms
|
Balazs Halmos, MD
|
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Pragmatic Clinical Trial To Evaluate The Effectiveness Of Low Dose Oral Methotrexate In Patients With Pediatric Crohn's Disease Initiating Anti-TNF Therapy (COMBINE)
|
Gastroenterology & Liver Diseases,Pediatrics,Inflammatory Bowel Disease,Colitis and Crohn's Disease
|
Gitit Tomer, MD
|
A Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study to Assess the Efficacy and Safety of REGN3500 Monotherapy and Combination of REGN3500 Plus Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis
|
Skin Disorders,Genetic Disorders,Dermatology,Immune System Diseases
|
Steven Cohen, MD
|
A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder.
|
Psychiatry - Non Cancer
|
Eric Hollander
|
A Randomized, Multicenter, Double Blind, Phase III Study of Adjuvant Nivolumab or Placebo in Subjects With Resected Esophageal, or Gastroesophageal Junction Cancer (CheckMate 577)
|
Gastrointestinal Cancer,Oncology (Medical/Hematologic),Cancer
|
Lakshmi Rajdev, MD
|
A randomized, open-label, multicenter, two arm, phase IIstudy to evaluate treatment compliance, efficacy and safety of an improved deferasirox formulation (granules) in pediatric patients with iron overload
|
Pediatric Hematology/Oncology
|
Deepa Manwani
|
A Randomized, Phase II Efficacy Assessment of Multiple MET Kinase Inhibitors (Cabozantinib [NSC #761968], Crizotinib [NSC #749005], Savolitinib [NSC #785348], and Sunitinib [NSC #736511]) in Metastatic Papillary Renal Carcinoma (PAPMET)
|
Kidney Diseases (incl Chronic Kidney Disease),Kidney Cancer,Oncology (Medical/Hematologic),Urologic Oncology (Med Onc),Carcinoma,Urogenital Neoplasms
|
Benjamin Gartrell, MD
|
A Randomized, Phase II Study Comparing Trastuzumab and Vinorelbine in Combination With Avelumab or Avelumab and Utomilumab (41BB/CD137 Agonist), in Patients With HER2-positive Metastatic Breast Cancer Who Have Progressed on Prior Trastuzumab and Pertuzum
|
Breast Cancer,Skin Disorders,Oncology (Medical/Hematologic),Neoplasms
|
Sun Young Oh, MD
|
A Randomized, Phase II/III Study of Pegylated Liposomal Doxorubicin and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin/Bevacizumab and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin/Bevacizumab in Platinum Resistant
|
Obstetrics & Gynecology and Women`s Health,Urologic Oncology (Med Onc),Cancer,Carcinoma,Urogenital Neoplasms
|
Nicole Nevadunsky, MD
|
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With = 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN+) After Neoadjuvant Chemotherapy
|
Breast Cancer,Women`s Health,Oncology (Medical/Hematologic),Carcinoma,Neoplasms
|
Jesus Anampa Mesias, MD
|
A Simple Walking Program to Enhance Concurrent Chemoradiotherapy Delivery
|
Gastrointestinal Cancer,Head and Neck Cancer,Women`s Health,Brain Cancer,Gastroenterology & Liver Diseases,Radiation Oncology,Urologic Oncology (Med Onc),Cancer,Neoplasms,Urogenital Neoplasms
|
Nitin Ohri, MD
|
A Study Evaluating the Pregnancy Outcomes and Safety of Interrupting Endocrine Therapy for Young Women With Endocrine Responsive Breast Cancer Who Desire Pregnancy (POSITIVE)
|
Breast Cancer,Women`s Health,Skin Disorders,Medical and Hematologic Oncology,Neoplasms
|
Joseph Sparano, MD
|
A Study to Compare Bone Marrow Transplantation to Standard Care in Adolescents and Young Adults With Severe Sickle Cell Disease (BMT CTN #1503)
|
Blood Disorders and Diseases,Genetic Disorders,Hematologic Diseases,Pediatrics,Sickle Cell,Anemia
|
Caterina Minniti, MD
|
A Study to Evaluate Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC) (B-FAST)
|
Lung Cancer,Oncology (Medical/Hematologic),Lung Diseases,Carcinoma,Neoplasms
|
Haiying Cheng, MD
|
A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
|
Prostate Cancer,Cardiology,Oncology (Medical/Hematologic),Urologic Oncology (Med Onc),Urogenital Neoplasms
|
Benjamin Gartrell, MD
|
A Trial of Endocrine Response in Women With Invasive Lobular Breast Cancer
|
Breast Cancer,Women`s Health,Oncology (Medical/Hematologic),Neoplasms
|
Joseph Sparano, MD
|
Abiraterone With Discontinuation of Gonadotropin-Releasing Hormone Analogues in Metastatic Prostate Cancer
|
Prostate Cancer,Oncology (Medical/Hematologic),Urologic Diseases,Urogenital Neoplasms
|
Benjamin Gartrell, MD
|
Achieving Smoking Cessation Milestones in Opioid Treatment Patients: a Randomized 2 x 2 Factorial Trial of Directly Observed and Long-term Varenicline
|
Mental Health and Disorders,Addiction,Smoking Cessation
|
Shadi Nahvi, MD
|
Adapting, Scaling, and Spreading an Algorithmic Asthma Mobile Intervention to Promote Patient-Reported Outcomes Within Primary Care Settings
|
Asthma and other Respiratory Diseases,Geriatrics,Lung Diseases,Immune System Diseases
|
Sunit Jariwala, MD
|
Alternate Approaches for Clinical Stage II or III Estrogen Receptor Positive Breast Cancer Neoadjuvant Treatment (ALTERNATE) in Postmenopausal Women: A Phase III Study
|
Breast Cancer,Women`s Health,Skin Disorders,Medical and Hematologic Oncology,Carcinoma,Neoplasms
|
Della Makower, MD
|
Ambulatory Gynecologic Surgery: Finding the Optimal Postoperative Opioid Prescription
|
Anesthesia and Pain Management,Obstetrics & Gynecology and Women`s Health
|
Ja Hyun Shin, MD
|
An ED-based Randomized Trial of IV Acetaminophen Versus IV Hydromorphone for Elderly Adults With Acute Severe Pain
|
Emergency Medicine,Urologic Diseases,Geriatrics,Pain Management
|
Alexander Latev, MD
|
An ED-based Randomized Trial of IV Acetaminophen Versus IV Hydromorphone for Elderly Adults With Acute Severe Pain
|
Anesthesia and Pain Management,Emergency Medicine,Urologic Diseases,Geriatrics
|
Alexander Latev, MD
|
An Intermediate-size, Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease
|
Pediatric Hematology/Oncology
|
Kris Mahadeo
|
An Observational Study in Differentiated Thyroid Cancer Which is Radioactive Iodine (RAI) Refractory to Assess the Use of Multikinase Inhibitors (RIFTOS MKI)
|
Head and Neck Cancer
|
Missak Haigentz, MD
|
An Observational, Multicenter Study of the Prevalence of Cerebrotendinous Xanthomatosis (CTX) in Patient Populations Diagnosed With Early-Onset Idiopathic Bilateral Cataracts
|
Genetic Disorders,Pediatrics,Ophthalmic Diseases and Disorders
|
Norman Medow, MD
|
An Open Label, Phase 2 Pharmacokinetic Study of Pre-Surgical Intramuscular and Intraductal Fulvestrant in Women With Invasive Breast Cancer or DCIS Undergoing Mastectomy or Lumpectomy
|
Breast Cancer,Women`s Health,Skin Disorders,Surgery,Family and Social Medicine,Carcinoma,Neoplasms
|
Sheldon Feldman, MD
|
An Open-label, Multicenter Phase 1 Study to Characterize the Safety, Tolerability, Preliminary Antileukemic Activity, Pharmacokinetics, and Maximum Tolerated Dose or Pharmacological Active Dose of BAY2402234 in Patients With Advanced Myeloid Malignancies
|
Myelodysplastic Syndrome (MDS),Leukemia,Cancer,Neoplasms
|
Amit Verma, MD
|
An Open-Label, Randomized Phase 3 Study to Evaluate Enfortumab Vedotin vs Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)
|
Bladder Cancer,Metastatic Cancer,Oncology (Medical/Hematologic),Urologic Oncology (Med Onc),Urologic Diseases,Geriatrics,Neoplasms,Urogenital Neoplasms
|
Benjamin Gartrell, MD
|
An Open-Label, Single-Arm, Phase 2 Study of AVB-620 in Women with Primary, Nonrecurrent Breast Cancer Undergoing Surgery
|
Breast Cancer,Women`s Health,Skin Disorders,Surgery,Carcinoma,Neoplasms
|
Sheldon Feldman, MD
|
Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-in Incident Dialysis (ASCEND-ID)
|
Kidney Diseases (incl Chronic Kidney Disease),Hematologic Diseases,Nephrology,Urologic Diseases,Anemia
|
Matthew Abramowitz, MD
|
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
|
Kidney Diseases (incl Chronic Kidney Disease),Hematologic Diseases,Nephrology,Urologic Diseases,Geriatrics,Anemia
|
Matthew Abramowitz, MD
|
Aneurysm Treatment Using the Heli-FX Aortic Securement System Global Registry (ANCHOR)
|
Heart and Vascular Diseases,Cardiovascular and Thoracic Surgery,Aneurysm
|
Evan Lipsitz, MD
|
Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer: A Prospective Randomized Open Blinded End-Point (Probe) Study
|
Cardiology,Oncology (Medical/Hematologic),Cancer,Embolism or Thrombosis
|
Henny Billett, MD
|
Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy (ADVANCE)
|
Skin Disorders,Dermatology,Psoriasis
|
Holly Kanavy, MD
|
ARCHIVE: A registry for children with vasculitis: e-entry
|
Heart and Vascular Diseases,Rheumatic Diseases,Pediatrics,Autoimmune Diseases
|
Maria Yee, MD
|
Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast Surgery
|
Breast Cancer,Oncology (Medical/Hematologic),Radiation Oncology,Neoplasms
|
Joseph Sparano, MD
|
Assessing the Efficacy of Virtual Reality Analgesia (VRA) in Adult Patients for Pain Control During Spinal Injections (SI) (VR Adult)
|
Anesthesia and Pain Management,Rehabilitation Medicine,Spinal Cord Diseases,Pain Management
|
Soo Yeon Kim, MD
|
Assessing the Efficacy of Virtual Reality Analgesia (VRA) in Pediatric Patients for Pain Control During Botox Injections for Spasticity Management: A Randomized Control Trial
|
Anesthesia and Pain Management,Pediatrics,Rehabilitation Medicine
|
Yuxi Chen, MD
|
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke (ARCADIA)
|
Heart and Vascular Diseases,Brain and Neurological,Neurology,Stroke and Cerebrovascular Diseases
|
Kathryn Kirchoff-Torres, MD
|
Autism Genetics Network, Phase II: Increasing Representation of Human Diversity
|
Autism Spectrum Disorder,Genetic Disorders,Neurology,Pediatrics
|
Sophie Molholm, PhD
|
Beta Adrenergic Receptor Blockade as a Novel Therapy for Patients With Adenocarcinoma of the Prostate
|
Prostate Cancer,Oncology (Medical/Hematologic),Urologic Oncology (Med Onc),Urologic Diseases,Carcinoma,Neoplasms,Urogenital Neoplasms
|
Benjamin Gartrell, MD
|
Bezlotoxumab (MK-6072) Versus Placebo in Children With Clostridium Difficile Infection (CDI) (MK-6072-001) (MODIFY III)
|
Infectious Diseases,Pediatrics,Immune System Diseases
|
David Goldman, MD
|
Breast Cancer WEight Loss Study (BWEL Study)
|
Breast Cancer,Women`s Health,Skin Disorders,Overweight, Obesity and Weight Loss,Carcinoma,Neoplasms
|
Della Makower, MD
|
Brentuximab Vedotin and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Hodgkin Lymphoma
|
Blood and Bone Marrow Cancer,Pediatric Hematology/Oncology,Lymphoma,Lymphatic and Spleen Diseases,Neoplasms,Lymphoproliferative Disorders,Immune System Diseases
|
Lisa Gennarini, MD
|
Buprenorphine Group Medical Visits for Drug Users at Risk for HIV
|
HIV/AIDS,Addiction,General Internal Medicine
|
Aaron Fox, MD
|
Buprenorphine Treatment at Syringe Exchanges to Reduce Opioid Misuse and HIV Risk
|
Mental Health and Disorders,Addiction
|
Aaron Fox, MD
|
Cabozantinib-S-Malate in Treating Patients With Advanced Solid Tumors and Human Immunodeficiency Virus
|
Solid Tumor,HIV/AIDS,Infectious Diseases,Oncology (Medical/Hematologic),Sexually Transmitted Diseases (STD),Neoplasms
|
Lakshmi Rajdev, MD
|
Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)
|
Autism Spectrum Disorder,Child Development,Neurodevelopmental Disorders
|
Eric Hollander, MD
|
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure (CONNECT-HF)
|
Heart and Vascular Diseases,Cardiology,Heart Failure
|
Richard Lucariello, MD
|
Chemotherapy Before Surgery and Tissue Sample Collection in Patients With Stage IIA-IIIC Breast Cancer
|
Breast Cancer,Skin Disorders,Neoplasms
|
Joseph Sparano, MD
|
Childhood Asthma Perception Study (CAPS)
|
Asthma and other Respiratory Diseases,Allergy and Immune Disorders,Allergy & Immunology,Pediatrics
|
Jonathan Feldman, PhD
|
Clinical Study to Assess the Efficacy and Safety of Macitentan in Patients With Pulmonary Hypertension After Left Ventricular Assist Device Implantation (SOPRANO)
|
Heart and Vascular Diseases,Cardiology,Pulmonary Hypertension,Lung Diseases
|
Ulrich Jorde, MD
|
COG-AALL0932 Treatment of Patients with Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B-lineage Lymphoblastic Lymphoma (B-LLy)
|
Pediatric Hematology/Oncology
|
Lisa Figueiredo
|
COG-AALL1131 A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND 73789, NSC 606869) in the Very High Risk Stratum
|
Pediatric Hematology/Oncology
|
Lisa Figueiredo
|
COG-AAML1031 A Phase III Randomized Trial for Patients with de novo AML using Bortezomib and Sorafenib (IND114480 NSC 681239, NSC 724772) for Patients with High Allelic Ratio FLT3/ITD
|
Pediatric Hematology/Oncology
|
Lisa Figueiredo
|
COG-ACCL1033 A Comprehensive Approach to Improve Medication Adherence in Pediatric ALL
|
Pediatric Hematology/Oncology
|
Lisa Figueiredo
|
COG-AEWS1031 A Phase III Randomized Trial of Adding Vincristine-Topotecan-Cyclophosphamide to Standard Chemotherapy in Initial Treatment of Non-metastatic Ewing Sarcoma
|
Pediatric Hematology/Oncology
|
Lisa Figueiredo
|
COG-ANBL00B1 Neuroblastoma Biology Studies
|
Neuroblastoma,Medical and Hematologic Oncology,Neoplasms
|
Lisa Gennarini, MD
|
COG-ANBL1232 Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High-Risk Neuroblastoma
|
Pediatric Hematology/Oncology
|
Lisa Figueiredo
|
COG-ANHL12P1 A Randomized Phase II study of Brentuximab Vedotin (NSC 749710) and Crizotinib (NSC 749005) in Patients with Newly Diagnosed Anaplastic Large Cell Lymphoma (ALCL) IND 117117
|
Pediatric Hematology/Oncology
|
Jonathan Gill
|
Cognitive Intervention to Improve Simple and Complex Walking
|
Brain and Neurological,Aging,Geriatrics,Cognitive Impairment
|
Joe Verghese, MD
|
Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies
|
Gastrointestinal Cancer,HIV/AIDS,Anal Cancer,Cancer and Genetics,Gastroenterology & Liver Diseases,Oncology (Medical/Hematologic),Urologic Oncology (Med Onc),Lymphatic and Spleen Diseases,Lymphoproliferative Disorders,Urogenital Neoplasms,Immune System Diseases
|
Joseph Sparano, MD
|
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations
|
Blood and Bone Marrow Cancer,Pediatric Hematology/Oncology,Leukemia,Lymphoma,Lymphatic and Spleen Diseases,Neoplasms,Lymphoproliferative Disorders,Immune System Diseases
|
Lisa Gennarini, MD
|
Combination Chemotherapy, Gemcitabine Hydrochloride, and Radiation Therapy Before Surgery in Treating Patients With Borderline Resectable Pancreatic Cancer
|
Gastrointestinal Cancer,Pancreatic Cancer,Gastroenterology & Liver Diseases,Oncology (Medical/Hematologic),Carcinoma,Neoplasms
|
Lakshmi Rajdev, MD
|
COMMUNITY CENTRAL LINE INFECTION PREVENTION (CCLIP) Trial
|
Pediatric Hematology/Oncology
|
Jennifer Davila
|
Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS: A Phase III Prospective Randomized Trial
|
Breast Cancer,Family and Social Medicine,Oncology (Medical/Hematologic),Carcinoma,Neoplasms
|
Sheldon Feldman, MD
|
Consideration of Pedicle Screw Misplacement on a Per-Patient Basis: Can we Better Delineate Surgical Risk?
|
Bones, Muscles & Joints (Orthopaedics)
|
Vishal Sarwahi, MD
|
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
|
Lung Cancer,Solid Tumor,Lung Diseases,Carcinoma,Neoplasms
|
Haiying Cheng, MD
|
Defensin and Innate Mucosal Immune Mediator Expression in Pediatric Inflammatory Bowel Disease
|
Gastroenterology & Liver Diseases,Pediatrics,Inflammatory Bowel Disease
|
Gitit Tomer, MD
|
Desmopressin as a Therapy for Nocturnal Enuresis in Patients with Sickle Cell Disease
|
Pediatric Hematology/Oncology
|
Kerry Morrone
|
Determining Change in Cardiovascular and Metabolic Risks in Patients With Chronic Phase Chronic Myeloid Leukemia Receiving BCR-ABL Tyrosine Kinase Inhibitor First-Line Therapy in the United States
|
Blood and Bone Marrow Cancer,Hematologic Diseases,Oncology (Medical/Hematologic),Leukemia,Neoplasms
|
Olga Derman, MD
|
Development of an Evidenced-Based Tool for Prediction of Sudden Death in Patients With Non-Ischemic Cardiomyopathy (NICMR)
|
Heart and Vascular Diseases,Cardiology
|
Mario Garcia, MD
|
Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM
|
Diabetes and Endocrine,Pediatric Endocrinology,Metabolic Diseases
|
Lisa Underland, MD
|
Does Pedicle Morphology Change with Age?
|
Bones, Muscles & Joints (Orthopaedics)
|
Vishal Sarwahi, MD
|
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer
|
Breast Cancer,Women`s Health,Skin Disorders,Carcinoma,Neoplasms
|
Della Makower, MD
|
Effect of Randomization to Neuromuscular Blockade on Physical Functional Impairment and Recovery in ARDS
|
Critical Care,Lung Diseases,Neuromuscular Diseases
|
Aluko Hope, MD
|
Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage IIB or IIIA Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)
|
Lung Cancer,Oncology (Medical/Hematologic),Lung Diseases,Carcinoma,Neoplasms
|
Balazs Halmos, MD
|
Efficacy of a Gluten-free Diet in Difficult to Manage Nephrotic Syndrome: Utility of Plasma Zonulin Levels as a Predictive Biomarker
|
Kidney Diseases (incl Chronic Kidney Disease),Nephrology,Pediatrics,Urologic Diseases
|
Frederick Kaskel, MD
|
Efficacy of Silicone Gel Versus Placebo for Postsurgical Scars of the Eyelid
|
Ophthalmic Diseases and Disorders
|
Anne Barmettler, MD
|
EFFICACY, SAFETY AND TOLERABILITY OF TOFACITINIB FORTREATMENT OF POLYARTICULAR COURSE JUVENILE IDIOPATHICARTHRITIS (JIA) IN CHILDREN AND ADOLESCENT SUBJECTS
|
Pediatrics
|
Dawn Wahezi
|
Elacestrant Monotherapy vs. Standard of Care for the Treatment of Patients With ER+/HER2- Advanced Breast Cancer Following CDK4/6 Inhibitor Therapy: A Phase 3 Randomized, Open-label, Active-controlled, Multicenter Trial
|
Breast Cancer,Skin Disorders,Oncology (Medical/Hematologic),Neoplasms
|
Joseph Sparano, MD
|
Electronic Monitoring of Medication Adherence in Moderate to Severe Asthma Patients
|
Pediatrics
|
Marina Reznik
|
EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study)
|
Heart and Vascular Diseases,Cardiology,Heart Failure
|
Jacqueline Lamour, MD
|
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
|
Lung Cancer,Lung Diseases,Carcinoma,Neoplasms
|
Haiying Cheng, MD
|
EVALUATING THE BENEFIT OF CONCURRENT TRICUSPID VALVE REPAIR DURING MITRAL SURGERY
|
Cardiovascular and Thoracic Surgery
|
Robert Michler, MD
|
Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug- Eluting StEnts The ECLIPSE Trial
|
Heart and Vascular Diseases
|
Giora Weisz, MD
|
Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3)
|
Gynecologic Oncology,Obstetrics & Gynecology and Women`s Health,Human Papilloma Virus (HPV),Carcinoma,Urogenital Neoplasms
|
Anne Van Arsdale, MD
|
Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery
|
Pancreatic Cancer
|
Steven Libutti, MD
|
Exemestane With or Without Entinostat in Treating Postmenopausal Patients With Recurrent Hormone Receptor-Positive Breast Cancer That Is Locally Advanced or Metastatic
|
Breast Cancer
|
Della Makower, MD
|
Exploratory Study Of The ERCC-1 Gene Expression In Colorectal Cancer Cell Lines And In Patients With Colorectal Cancer
|
Colon, Colorectal and Rectal Cancer
|
Sanjay Goel, MD
|
FIRSTx - A Phase 2 Multicenter, Open Label, Randomized Study of Two Titration Regimens of Oral CXA-10 in Subjects With Primary Focal Segmental Glomerulosclerosis (FSGS)
|
Kidney Diseases (incl Chronic Kidney Disease),Urologic Diseases,Nephrotic Syndrome
|
Tanya Johns, MD
|
FLT3 Ligand Immunotherapy and Stereotactic Radiotherapy for Advanced Non-small Cell Lung Cancer (FLT3)
|
Lung Cancer
|
Nitin Ohri, MD
|
Follow-up study of children with early diagnosis of autism spectrum disorder
|
Autism Spectrum Disorder
|
Lisa Shulman, MD
|
Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery
|
Breast Cancer
|
Della Makower, MD
|
Gene Discoveries in Subjects with Crohns Disease of African Descent
|
|
Gitit Tomer, MD
|
Genetic Predisposition to Appendicitis: A Pilot Study
|
Surgery
|
Dominique Jan, MD
|
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
|
Lung Cancer,Cancer and Genetics
|
Steven Keller, MD
|
Global Congestive Heart Failure (G-CHF) Study: A Global Registry to Study the Demographics, Socioeconomic and Clinical Factors, Etiologies, Pathophysiology, Management, Barriers to Care, and Outcomes of Heart Failure Patients
|
Heart and Vascular Diseases,Cardiology,Heart Failure
|
Ileana Pina, MD
|
HEALTHCALL ENHANCING BRIEF INTERVENTION FOR HIV PRIMARY CARE ALCOHOL DEPENDENCE
|
Infectious Diseases
|
Barry Zingman, MD
|
Hematology Biobank : Invitro Study of Blood Disorders
|
Blood Disorders and Diseases,Hematologic Diseases
|
Henny Billett, MD
|
High Risk Multiple Gestation Study
|
Women`s Health
|
Peer Dar, MD
|
Hydroxyurea Adherence for Personal Best in Sickle Cell Disease (HABIT): Efficacy Trial
|
Genetic Disorders,Hematologic Diseases,Pediatric Hematology/Oncology,Pediatrics,Anemia
|
Deepa Manwani, MD
|
Ibrutinib in Combination With Corticosteroids Versus Placebo in Combination With Corticosteroids in Subjects With New Onset Chronic Graft Versus Host Disease (cGVHD) (INTEGRATE)
|
Graft Versus Host Disease (GVHD)
|
Olga Derman, MD
|
Immediate postpartum contraceptive implant placement and breastfeeding success in women at risk for low milk supply a randomized non-inferiority trial
|
Obstetrics & Gynecology and Women`s Health
|
Erika Levi, MD
|
Implementation of a Prospective Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer
|
Colon, Colorectal and Rectal Cancer,Gastrointestinal Cancer,Gastroenterology & Liver Diseases,Oncology (Medical/Hematologic),Neoplasms
|
Sanjay Goel, MD
|
Infantile Spasms Multicenter Database
|
Brain and Neurological
|
Elissa Yozawitz, MD
|
Insights Into Microbiome and Environmental Contributions to Sickle Cell Disease and Leg Ulcers Study (INSIGHTS Study)
|
Blood Disorders and Diseases
|
Caterina Minniti, MD
|
International Registry for Severe Chronic Neutropenia
|
Blood Disorders and Diseases
|
Kerry Morrone, MD
|
Intravenous Gammaglobulin for Sickle Cell Pain Crises
|
Anesthesia and Pain Management,Blood Disorders and Diseases
|
Deepa Manwani, MD
|
L-citrulline for Prevention of Sequelae of Acute Lung Injury in Pediatrics Undergoing Cardiopulmonary Bypass for Heart Defects
|
Cardiovascular and Thoracic Surgery
|
Giles Peek, MD
|
LEFT ATRIAL APPENDAGE LIGATION WITH THE LARIAT-SUTURE DELIVERY SYSTEM AS ADJUNCTIVE THERAPY TOPULMONARY VEIN ISOLATION FOR PERSISTENT ORLONGSTANDING PERSISTENT ATRIAL FIBRILLATION
|
Cardiology
|
Luigi Di Biase, MD, PhD
|
Longitudinal Clinical Evaluation of the HPV Assay on the BD VIPER LT System With Cervical Specimens
|
Women`s Health
|
Heather Smith, MD
|
Longitudinal Cohort Study in Participants With Severe Asthma to Assess Biomarkers
|
Asthma and other Respiratory Diseases
|
Golda Hudes, MD
|
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
|
Lung Cancer
|
Haiying Cheng, MD
|
Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients With Newly Diagnosed Ependymoma
|
Brain and Neurological
|
Lisa Gennarini, MD
|
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
|
Lung Cancer,Radiation Oncology,Lung Diseases,Carcinoma,Neoplasms
|
Nitin Ohri, MD
|
MarginProbe® System U.S. Post-Approval Study Protocol CP-07-001
|
Breast Cancer,Women`s Health,Surgery,Family and Social Medicine,Carcinoma
|
Sheldon Feldman, MD
|
Matched Targeted Therapy (MTT) Recommendation for Patients with Recurrent, Refractory, or High Risk Leukemias
|
Blood Disorders and Diseases,Pediatric Hematology/Oncology,Leukemia,Cancer,Neoplasms
|
Lisa Gennarini, MD
|
Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain Metastases
|
Brain Cancer,Metastatic Cancer
|
William Bodner, MD
|
Metformin in Children With Relapsed or Refractory Solid Tumors
|
Solid Tumor
|
Daniel Weiser, MD
|
Modifiers of PrEP Efficacy Impact of the Vaginal Microbiome and Age
|
Women`s Health,Urinary Disorders,Infectious Diseases,Sexually Transmitted Diseases (STD)
|
Marla Keller, MD
|
Molecular and Genomic Profiling of Head and Neck Tumors
|
Lung Cancer,Cancer and Genetics
|
Richard Smith, MD
|
Molecular Basis of Early Childhood Obesity Programming by Intrauterine Growth Restriction
|
Overweight, Obesity and Weight Loss,Pediatrics,Neonatology
|
Mamta Fuloria, MD
|
Monitoring Neoadjuvant Chemotherapy Response In Breast Cancer Patients Using Diffuse Optical Spectroscopic Imaging (DOSI)
|
Breast Cancer,Bones, Muscles & Joints (Orthopaedics),Orthopedic Surgery - Cancer,Neoplasms
|
Bang Hoang, MD
|
Montefiore Opioid and Pain Study (MOPS)
|
Anesthesia and Pain Management,Emergency Medicine
|
Benjamin Friedman, MD
|
Mood disorder and cognitive dysfunction in pediatric lupus
|
Rheumatic Diseases
|
Chaim Putterman, MD
|
Motor Imagery A Pilot Intervention for Improving Gait and Cognition in the Elderly
|
Aging,Geriatrics
|
Helena Blumen, MD
|
Multicenter Cohort Study To Evaluate Outcomes After Receipt of Targeted Therapy Matched to an Individualized Cancer Therapy (iCat) Recommendations in Children and Young Adults With Solid Tumors: The iCat2, GAIN Consortium Study
|
Solid Tumor,Hematologic Diseases,Pediatric Hematology/Oncology,Cancer
|
Daniel Weiser, MD
|
Multicenter Expanded Access Protocol of Allogeneic Epstein-Barr Virus Cytotoxic T Lymphocytes (EBV-CTLs) for Patients with EBV-Associated Viremia or Malignancies for Whom there are No Appropriate Alternative Therapies
|
Pediatric Hematology/Oncology
|
Lisa Figueiredo
|
Multicenter Prospective Cohort Study on Current Treatments of Legg-Calvé-Perthes Disease (IPSG1)
|
Bones, Muscles & Joints (Orthopaedics)
|
Eric Fornari, MD
|
Multicenter, Open Label, Phase 3 Study of Tabelecleucel for Solid Organ Transplant Subjects With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure of Rituximab or Rituximab and Chemotherapy (ALLELE)
|
Pediatric Hematology/Oncology,Pediatrics,Solid Organ Transplant (SOT) Complications,Epstein-Barr Virus (EBV),Lymphoproliferative Disorders,Immune System Diseases
|
David Loeb, MD
|
Multicenter, Open Label, Phase 3 Study of Tabelecleucel for Solid Organ Transplant Subjects With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure of Rituximab or Rituximab and Chemotherapy (ALLELE)
|
Medical and Hematologic Oncology,Solid Organ Transplant (SOT) Complications,Epstein-Barr Virus (EBV),Lymphoproliferative Disorders,Immune System Diseases
|
Ioannis Mantzaris, MD
|
Multicenter, Open-label, Clinical and Pharmacokinetic Study of PM060184 in Combination With Gemcitabine in Selected Patients With Advanced Solid Tumors
|
Solid Tumor
|
Sanjay Goel, MD
|
Multicenter, Open-Label, Phase 3 Study of Tabelecleucel for Allogeneic Hematopoietic Cell Transplant Subjects With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure of Rituximab (MATCH Study)
|
Pediatric Hematology/Oncology,Cancer,Lymphoma,Lymphatic and Spleen Diseases,Epstein-Barr Virus (EBV),Lymphoproliferative Disorders,Immune System Diseases
|
David Loeb, MD
|
Multicultural Healthy Diet to Reduce Cognitive Decline & Alzheimer's Disease Risk
|
Mental Health and Disorders,Brain and Neurological,Endocrinology,Aging,Alzheimer's Disease,Cognitive Impairment
|
Yasmin Mossavar-Rahmani, MD
|
Myocardial Ischemia and Transfusion
|
Cardiology
|
Mark Menegus, MD
|
Natural History Study of the Development of Type 1 Diabetes
|
Diabetes and Endocrine,Endocrinology,Autoimmune Diseases,Metabolic Diseases
|
Lisa Underland, MD
|
NCI-MATCH: Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors or Lymphomas
|
Solid Tumor,Blood and Bone Marrow Cancer
|
Balazs Halmos, MD
|
Nephrotic Syndrome Study Network Under the Rare Diseases Clinical Research Network (NEPTUNE)
|
Kidney Diseases (incl Chronic Kidney Disease),Pediatrics,Urologic Diseases,Geriatrics,Nephrotic Syndrome,Immune System Diseases
|
Frederick Kaskel, MD
|
Neuropsychological and Behavioral Testing in Younger Patients With Cancer
|
Supportive Cancer Care
|
Lisa Gennarini, MD
|
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial) (ANVIL)
|
Lung Cancer,Medical and Hematologic Oncology,Lung Diseases,Carcinoma,Neoplasms
|
Haiying Cheng, MD
|
Nivolumab and Ipilimumab in Treating Patients With Advanced HIV Associated Solid Tumors
|
Solid Tumor,HIV/AIDS
|
Lakshmi Rajdev, MD
|
Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)
|
Allergy and Immune Disorders
|
Arye Rubinstein, MD
|
Noninvasive Monitoring of Uterine Electrical Activity and Fetal Heart Rate: A New External Monitoring Device
|
Women`s Health,Obstetrics & Gynecology and Women`s Health
|
Peter Bernstein, MD
|
North American Pediatric Renal Trials and Collaborative Studies
|
Kidney Diseases (incl Chronic Kidney Disease)
|
Marcela Del Rio, MD
|
Novel Approach for the Prevention of Hypoglycemia Associated Autonomic Failure (HAAF)
|
Diabetes and Endocrine,Endocrinology,Autoimmune Diseases,Metabolic Diseases,Nervous System Diseases
|
Meredith Hawkins, MD
|
NRG-GI002 A Phase II Clinical Trial Platform of Sensitization Utilizing Total Neoadjuvant Therapy (TNT) in Rectal Cancer
|
Radiation Oncology
|
Rafi Kabarriti, MD
|
Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC) (TRUMPET)
|
Prostate Cancer
|
Benjamin Gartrell, MD
|
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
|
Rheumatic Diseases
|
Yonit Sterba Ruas, MD
|
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer (OlympiA)
|
Breast Cancer
|
Jesus Anampa Mesias, MD
|
Omega-3 Replacement With Krill Oil in Disease Management of SLE (ORKIDS)
|
Rheumatic Diseases,Lupus,Autoimmune Diseases,Immune System Diseases
|
Chaim Putterman, MD
|
Open-label, Phase I/II Study to Evaluate Pharmacokinetics, Pharmacodynamics, Safety, and Anticancer Activity of Avelumab in Pediatric Subjects From Birth to Less Than 18 Years of Age With Refractory or Relapsed Solid Tumors and Lymphoma
|
Solid Tumor,Pediatric Hematology/Oncology,Lymphoma,Lymphatic and Spleen Diseases,Neoplasms,Lymphoproliferative Disorders,Immune System Diseases
|
David Loeb, MD
|
OPtical Coherence Tomography (OCT) Guided Coronary Stent IMplantation Compared to Angiography: a Multicenter Randomized TriaL in PCI
|
Heart and Vascular Diseases,Cardiology
|
Giora Weisz, MD
|
Outcomes of Neonatal Acute Kidney Injury In Premature Infants
|
Kidney Diseases (incl Chronic Kidney Disease)
|
Mamta Fuloria, MD
|
Patient Empowered Strategy to Reduce Asthma Morbidity in Highly Impacted Populations (PREPARE)
|
Asthma and other Respiratory Diseases,Family and Social Medicine,Lung Diseases
|
Melissa Mckee, MD
|
Patient-Derived Models Tissue Procurement Protocol for the National Cancer Institute (NCI)
|
Oncology (Medical/Hematologic),Cancer,Neoplasms
|
Joseph Sparano, MD
|
Patient-Reported Outcomes Following Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer: A Randomized Trial Comparing Two Radiotherapy Schedules
|
Lung Cancer,Radiation Oncology,Lung Diseases,Carcinoma,Neoplasms
|
Nitin Ohri, MD
|
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery
|
Kidney Cancer
|
Benjamin Gartrell, MD
|
PC4PrEP: Integrating Pre-Exposure Prophylaxis (PrEP) Into Primary Care
|
HIV/AIDS,Infectious Diseases,Human Papilloma Virus (HPV),Sexually Transmitted Diseases (STD)
|
Laurie Bauman, MD
|
Ped Cardiac Quality of LIfe
|
Heart and Vascular Diseases
|
Jacqueline Lamour, MD
|
Pediatric Heart Transplant Study Group
|
Heart and Vascular Diseases
|
Jacqueline Lamour, MD
|
Peer Mentor Training to Reduce Hospitalizations for Children With Asthma
|
Asthma and other Respiratory Diseases,Pediatrics,Lung Diseases
|
Deepa Rastogi, MD
|
Peer Mentorship to Improve Outcomes in Patients on Maintenance Hemodialysis
|
Kidney Diseases (incl Chronic Kidney Disease),Emergency Medicine,Nephrology
|
Ladan Golestaneh, MD
|
PERL (Preventing Early Renal Loss in Diabetes) Continuous Glucose Monitoring (CGM) Study
|
Diabetes and Endocrine,Kidney Diseases (incl Chronic Kidney Disease),Endocrinology,Urologic Diseases
|
Jill Crandall, MD
|
Personalized Medicine: Pediatric Total Cancer Care™ Protocol
|
Supportive Cancer Care
|
Daniel Weiser, MD
|
Pharmacodynamic & Safety of Patiromer in Children & Adolescents (2-<18 Yrs) With Chronic Kidney Disease and Hyperkalemia (EMERALD)
|
Kidney Diseases (incl Chronic Kidney Disease)
|
Anna Zolotnitskaya, MD
|
Pharmacokinetics and Pharmacodynamics Study of SEG101 (Crizanlizumab) in Adult Sickle Cell Disease (SCD) Patients With Vaso- Occlusive Crisis (VOC)
|
Sickle Cell
|
Deepa Manwani, MD
|
Phase 1/2 Study of Vactosertib (TEW-7197) Monotherapy in Patients With Low or Intermediate Myelodysplastic Syndromes
|
Blood and Bone Marrow Cancer,Myelodysplastic Syndrome (MDS),Hematologic Diseases,Oncology (Medical/Hematologic),Cancer,Neoplasms
|
Amit Verma, MD
|
Phase 1/2, First-in-Human, Dose-Escalation Study of X-396 in Patients With Advanced Solid Tumors and Expansion Phase in Patients With ALK-positive Non-Small Cell Lung Cancer
|
Lung Cancer,Solid Tumor
|
Haiying Cheng, MD
|
Phase 1/2, Multicenter, Open-label, Multiple-Dose First-in-human Study of U3-1402, in Subjects With HER3 Positive Metastatic Breast Cancer
|
Breast Cancer,Skin Disorders,Metastatic Cancer,Oncology (Medical/Hematologic),Neoplasms
|
Sun Young Oh, MD
|
Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy (OPUS)
|
Neurology,Epilepsy
|
Alexis Boro, MD
|
Phase 2 Multi-center Study of Pembrolizumab in Combination With Platinum-based Doublet Chemotherapy in Patients With EGFR Mutation and ALK Positive NSCLC (Non-Small Cell Lung Cancer) w/Progressive Disease Following Prior Tyrosine Kinase Inhibitors (TKIs)
|
Lung Cancer,Lung Diseases,Carcinoma,Neoplasms
|
Balazs Halmos, MD
|
Phase 2 Randomized, Double-Blinded, Controlled Study of Tucatinib vs. Placebo in Combination with Capecitabine and Trastuzumab in Patients with Pretreated Unresectable Locally Advanced or Metastatic HER2 Breast Carcinoma
|
Breast Cancer
|
Sun Young Oh, MD
|
Phase 2 Study of Denosumab (IND 127430, NSC 744010), a Rank Ligand Antibody, for Recurrent or Refractory Osteosarcoma
|
Pediatric Hematology/Oncology
|
Lisa Figueiredo
|
Phase 2 Study: Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Children and Adolescents With Prader-Willi Syndrome
|
Child Development,Genetic Disorders,Pediatrics,Psychiatry - Non Cancer,Nervous System Diseases
|
Eric Hollander, MD
|
Phase 2 Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 20 mg or 14 mg Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety
|
Thyroid Cancer
|
Missak Haigentz, MD
|
Phase 2a Study of BAX69 and 5-FU/Leucovorin or Panitumumab Versus Standard of Care in Subjects With Metastatic Colorectal Cancer
|
Colon, Colorectal and Rectal Cancer
|
Sanjay Goel, MD
|
PHASE 3 STUDY OF IV TO ORAL 6-DAY TEDIZOLID PHOSPHATE COMPARED WITH 10-DAY COMPARATOR IN SUBJECTS 12 TO
|
Pediatrics
|
David Goldman
|
Phase I and Dose-Expansion Study of Ibrutinib and R-da-EPOCH for Front Line Treatment of AIDS-Related Lymphomas
|
HIV/AIDS,Oncology (Medical/Hematologic),Lymphoma,Sexually Transmitted Diseases (STD),Lymphatic and Spleen Diseases,Neoplasms
|
Ioannis Mantzaris, MD
|
Phase I TITE-CREM Dose Escalation Study of Fractionated Stereotactic Radiation Therapy (FSRT) in Unresected Brain Metastases
|
Brain and Neurological,Brain Cancer,Radiation Oncology,Neoplasms,Nervous System Diseases
|
Madhur Garg, MD
|
Phase I/II Trial of Ruxolitinib in Combination With Trastuzumab in Metastatic HER2 Positive Breast Cancer
|
Breast Cancer
|
Della Makower, MD
|
Phase Ib Feasibility Trial of Neoadjuvant Nivolumab/Lirilumab in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
|
Bladder Cancer,Oncology (Medical/Hematologic),Urologic Oncology (Med Onc),Urologic Diseases,Neoplasms
|
Benjamin Gartrell, MD
|
Phase Ib/II Study of Concurrent Durvalumab And Radiation Therapy (DUART) Followed by Adjuvant Durvalumab in Patients With Urothelial Cancer (T2-4 N0-2 M0) of the Bladder: Big Ten Cancer Research Consortium BTCRC-GU15-023
|
Bladder Cancer,Urologic Oncology (Med Onc),Urologic Diseases,Neoplasms
|
Alexander I. Sankin, MD
|
Phase II Randomized Trial of Radiotherapy With or Without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) With TP53 Sequencing
|
Head and Neck Cancer,Oncology (Medical/Hematologic),Carcinoma,Neoplasms
|
Balazs Halmos, MD
|
Phase II Study of Lenalidomide and Eltrombopag in Patients with Symptomatic Anemia in Low or Intermediate I Myelodysplastic Syndrome
|
Blood and Bone Marrow Cancer,Myelodysplastic Syndrome (MDS)
|
Amit Verma, MD
|
Phase II Trial of Pembrolizumab (MK-3475) in Subjects with Metastatic Castration-Resistant Prostate Cancer (mCRPC)(KEYNOTE-199)
|
Prostate Cancer,Medical and Hematologic Oncology,Neoplasms
|
Benjamin Gartrell, MD
|
Phase II trial of topical sodium nitrite in patients with sickle cell disease and leg ulcers
|
Sickle Cell
|
Caterina Minniti, MD
|
Phase II Trial Testing the Antiemetic Efficacy of a Single-day Low Dose Aprepitant (or Fosaprepitant) Added to a 5-HT3 Receptor Antagonist Plus Dexamethasone in Patients Receiving Carboplatin
|
Oncology (Medical/Hematologic),Cancer
|
Richard Gralla, MD
|
Phase III Multicenter Open-label Randomized Clinical Trial Comparing Everolimus and Low Dose Tacrolimus to Tacrolimus and Mycophenolate Mofetil at 6 mo Post-Transplant to Prevent Long-term Complications After Pediatric Heart Transplantation
|
Kidney Diseases (incl Chronic Kidney Disease),Heart and Vascular Diseases,Cardiovascular and Thoracic Surgery,Pediatrics,Urologic Diseases
|
Jacqueline Lamour, MD
|
Phase III Randomized Adjuvant Study of MK-3475 (Pembrolizumab) in Muscle Invasive and Locally Advanced Urothelial Carcinoma (AMBASSADOR) Versus Observation
|
Bladder Cancer,Oncology (Medical/Hematologic),Carcinoma,Neoplasms
|
Benjamin Gartrell, MD
|
Pilot Study Assessing the Effect of Cyclin-dependent Kinase 4/6 Inhibitors on Body Composition in Patients With ER+/HER2- Metastatic Breast Cancer
|
Breast Cancer,Skin Disorders,Oncology (Medical/Hematologic),Neoplasms
|
Jesus Anampa Mesias, MD
|
Pilot Study of Adoptive Cell Transfer for the Treatment of Metastatic Cancer that Expresses NY-ESO-1 Using Lymphodepleting Conditioning Followed by Infusion of Anti-NY ESO-1 Murine TCR-Gene Engineered Lymphocytes
|
Brain Cancer,Metastatic Cancer,Medical and Hematologic Oncology,Oncology (Medical/Hematologic),Neoplasms
|
Ira Braunschweig, MD
|
Platinum Based Chemotherapy or Observation in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
|
Breast Cancer
|
Joseph Sparano, MD
|
Prediction of Functional Outcomes From Chronic Critical Illness
|
Critical Care
|
Aluko Hope, MD
|
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer (POSITIVE)
|
Breast Cancer
|
Joseph Sparano, MD
|
Problem Adaptation Therapy for Mild Cognitive Impairment and Depression
|
Depression,Psychiatry - Non Cancer,Geriatrics,Cognitive Impairment
|
Mirnova Ceide, MD
|
Project: Every Child for Younger Patients With Cancer
|
Cancer and Genetics
|
Lisa Gennarini, MD
|
Promoting Asthma Guidelines and Management through Technology-Based Intervention and Care Coordination (PRAGMATIC)
|
Asthma and other Respiratory Diseases,Pediatrics,Lung Diseases
|
Marina Reznik, MD
|
Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY): A Multi-Center International Randomized Controlled Trial Comparing Alternative Antibiotic Regimens in Patients Undergoing Tumor Resections With Endoprosthetic Replacements
|
Bone Cancer,Surgery,Infectious Diseases,Cancer,Musculoskeletal Diseases,Neoplasms
|
David Geller, MD
|
PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery
|
Colon, Colorectal and Rectal Cancer
|
Rebecca Levine, MD
|
Prospective Randomized Control Trial Evaluating Single Shot Exparel Versus Indwelling Interscalene Catheter for Total Shoulder Replacements- A Pilot Study
|
Anesthesia and Pain Management,Family and Social Medicine,Geriatrics,Nervous System Diseases
|
Elilary Montilla Medrano, MD
|
Prospective, Multi Centre, International Registry of Male and Female Patients Newly Diagnosed With Atrial Fibrillation
|
Heart and Vascular Diseases
|
Kevin Ferrick, MD
|
Protocol For A Research Database For Hematopoietic Stem Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries
|
Blood and Bone Marrow Cancer,Blood Disorders and Diseases,Hematologic Diseases,Oncology (Medical/Hematologic),Pediatric Hematology/Oncology,Neoplasms
|
Ira Braunschweig, MD
|
Protocol for a Research Sample Repository and for a Research Database for Hematopoietic Cell Transplantation, Other Cellular Therapies, and Marrow Toxic Injuries
|
Hematologic Diseases,Oncology (Medical/Hematologic),Pediatric Hematology/Oncology,Pediatrics,Neoplasms
|
David Loeb, MD
|
Protocol for a Research Sample Repository for Allogeneic Hematopoietic Stem Cell Transplantation
|
Blood and Bone Marrow Cancer,Blood Disorders and Diseases,Autoimmune Diseases
|
Ira Braunschweig, MD
|
Quarenta Semanas: Innovative Intervention in Prenatal Care for Reduction of Prematurity (quarenta)
|
Infant Care
|
Judy Aschner, MD
|
Radiation Therapy Sandwiched Between Paclitaxel and Carboplatin in Patients With High-risk Endometrial Cancer
|
Gynecologic Cancer
|
Dennis Kuo, MD
|
Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-Rhabdomyosarcoma Soft Tissue Sarcomas That Can be Removed by Surgery (PAZNTIS)
|
Soft Tissue Sarcoma/Cancer
|
Lisa Gennarini, MD
|
Randomized Clinical Trial of IV Acetaminophen as an Adjuvant Analgesic to IV Hydromorphone for Treatment of Acute Severe Pain in Non-Elderly Emergency Department Patients
|
Anesthesia and Pain Management,Emergency Medicine
|
Polly Bijur, MD
|
Randomized On-X Anticoagulation Trial
|
Heart and Vascular Diseases
|
Ricardo Bello, MD
|
Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)
|
Ears, Nose and Throat,Radiation Oncology,Carcinoma,Neoplasms
|
Madhur Garg, MD
|
Randomized Phase II Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC 750008, IND 120449) to Multiagent Chemotherapy for Patients with Newly Diagnosed Metastatic Ewing Sarcoma
|
Pediatric Hematology/Oncology
|
Lisa Figueiredo
|
Randomized Phase II/III Study of Combination of Cediranib and Olaparib Compared to Cediranib or Olaparib Alone, or Standard of Care Chemotherapy in Women w/Recurrent Platinum-Resistant or -Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
|
Gynecologic Cancer,Gynecologic Oncology,Obstetrics & Gynecology and Women`s Health,Carcinoma,Urogenital Neoplasms
|
Nicole Nevadunsky, MD
|
Randomized Study of Erlotinib vs Observation in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC) (An ALCHEMIST Treatment Trial)
|
Lung Cancer,Medical and Hematologic Oncology,Lung Diseases,Carcinoma,Neoplasms
|
Haiying Cheng, MD
|
Randomized Trial Of Hybrid Coronary Revascularization Versus Percutaneous Coronary Intervention
|
Heart and Vascular Diseases,Cardiovascular and Thoracic Surgery,Coronary Artery Bypass Grafting (CABG),Percutaneous Coronary Intervention (PCI)
|
Joseph De Rose, MD
|
Rebastinib Plus Antitubulin Therapy With Paclitaxel or Eribulin in Metastatic Breast Cancer
|
Breast Cancer
|
Jesus Anampa Mesias, MD
|
Reevaluation Of Systemic Early Neuromuscular Blockade (ROSE)
|
Asthma and other Respiratory Diseases,Critical Care
|
Michelle Gong, MD
|
Registry of Guardant360® Use and Outcomes In People With Advanced Cancer
|
Lung Cancer,Lung Diseases,Carcinoma
|
Balazs Halmos, MD
|
Regulation of Endogenous Glucose Production by Central KATP Channels
|
Diabetes and Endocrine,Metabolic Diseases
|
Meredith Hawkins, MD
|
RELIEVE-HF TRIAL: REducing Lung congestIon Symptoms Using the v-wavE Shunt in adVancEd Heart Failure
|
Heart and Vascular Diseases,Cardiology,Geriatrics,Lung Diseases,Heart Failure
|
Giora Weisz, MD
|
Reproductive Health Program in Patients With Cancer
|
Supportive Cancer Care
|
Della Makower, MD
|
Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma
|
Neuroblastoma
|
Peter Cole, MD
|
Restorelle® Mesh Versus Native Tissue Repair for Prolapse
|
Women`s Health
|
Keith Downing, MD
|
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
|
Blood and Bone Marrow Cancer
|
Peter Cole, MD
|
Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
|
Oncology (Medical/Hematologic),Leukemia,Non-Hodgkins Lymphoma,Lymphoma,Neoplasms,Epstein-Barr Virus (EBV),Lymphoproliferative Disorders
|
Lisa Gennarini, MD
|
RT CHARM: Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation With Breast Reconstruction
|
Breast Cancer,Women`s Health,Radiation Oncology,Carcinoma,Neoplasms
|
Jana Fox, MD
|
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer (e3)
|
Breast Cancer
|
Della Makower, MD
|
S1314, A Randomized Phase II Study of Co-Expression Extrapolation (COXEN) With Neoadjuvant Chemotherapy for Localized, Muscle-Invasive Bladder Cancer
|
Medical and Hematologic Oncology
|
Benjamin Gartrell, MD
|
S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer (COXEN)
|
Bladder Cancer
|
Benjamin Gartrell, MD
|
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
|
Pancreatic Cancer
|
Lakshmi Rajdev, MD
|
Safety and Effectiveness of Belimumab in Systemic Lupus Erythematosus Registry (SABLE)
|
Rheumatic Diseases
|
Chaim Putterman, MD
|
Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for the Treatment of Oral Cancers
|
Gastrointestinal Cancer,Head and Neck Cancer,Oncology (Medical/Hematologic),Radiation Oncology,Oral Mucositis
|
Rafi Kabarriti, MD
|
Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Surgery
|
Heart and Vascular Diseases,Surgery
|
Stuart Greenstein, MD
|
Safety and Pharmacokinetics of Atezolizumab Combination Treatments in Participants With HER2-Positive and HER2-Negative Breast Cancer
|
Medical and Hematologic Oncology
|
Sun Young Oh, MD
|
Safety Follow-up Through 180 Days of Treatment withRemestemcel-L in Study MSB-GVHD001 in Pediatric Patients who have Failed to Respond to Steroid Treatment for Acute GVHD
|
Pediatrics
|
Deepa Manwani
|
Safety Study of ALRN-6924 in Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome
|
Blood and Bone Marrow Cancer,Myelodysplastic Syndrome (MDS)
|
Amit Verma, MD
|
Safety Study of Gene Modified Donor T-cells Following TCR Alpha Beta Depleted Stem Cell Transplant
|
Blood and Bone Marrow Cancer
|
Kris Mahadeo, MD
|
Self regulation in children with learning disabilities and inattention/hyperactivity
|
Child Development
|
Katherine Lawson, PhD
|
Sensory Integration Therapy in Autism: Mechanisms and Effectiveness
|
Autism Spectrum Disorder
|
Sophie Molholm, PhD
|
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
|
Heart and Vascular Diseases,Cardiology,Heart Failure,Arrhythmia
|
Nils Guttenplan, MD
|
Simple Bone Cysts in Kids (SBoCK)
|
Bones, Muscles & Joints (Orthopaedics),Orthopaedic Surgery,Pediatrics,Musculoskeletal Diseases,Neoplasms
|
Jacob Schulz, MD
|
Single Arm Study Treating Patients of Peritoneal Surface Malignancy (Colorectal, Appendical, Pseudomyxoma, Gastric) With Cytoreductive Surgery and Hyperthermic Intraperitoneal Mitomycin-C
|
Gastrointestinal Cancer
|
Haejin In, MD
|
Single-dose Intraoperative Methadone for Early Ambulation and Sustained Pain Control in Spinal Fusion Surgery Patients
|
Surgery,Neurology,Postoperative Pain Management,Nervous System Diseases
|
Merritt Drew Kinon, MD
|
Social Dancing Intervention for Older Adults at High Risk of Alzheimer's Disease and Other Dementias: A Pilot Study
|
Brain and Neurological,Neurology,Aging,Alzheimer's Disease,Dementia,Nervous System Diseases
|
Joe Verghese, MD
|
Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer
|
Liver Cancer
|
Nitin Ohri, MD
|
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
|
Breast Cancer
|
Jana Fox, MD
|
Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918) (SMARTMSP)
|
Heart and Vascular Diseases,Cardiology
|
Luigi Di Biase, MD, PhD
|
Study of Acarbose in Longevity
|
Endocrinology
|
Erika Brutsaert, MD
|
Study of Allogeneic EBV-CTLs in EBV-Associated Viremia or Malignancies
|
Hematologic Diseases,Lymphoma
|
Murali Janakiram, MD
|
Study of Allogeneic EBV-CTLs in EBV-Associated Viremia or Malignancies
|
Hematologic Diseases,Pediatrics
|
David Loeb, MD
|
Study of Efficacy of Ribociclib After Progression on CDK4/6 Inhibition in Patients With HR+ HER2- Advanced Breast Cancer (MAINTAIN)
|
Breast Cancer,Women`s Health,Oncology (Medical/Hematologic),Carcinoma,Neoplasms
|
Sun Young Oh, MD
|
Study of Kidney Tumors in Young Patients
|
Kidney Cancer
|
Lisa Gennarini, MD
|
Study of the Safety and Effectiveness of SAMSCA® (Tolvaptan) in Children and Adolescents With Euvolemic or Hypervolemic Hyponatremia
|
Heart and Vascular Diseases
|
Scott Aydin,MD
|
Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With Cancer
|
Supportive Cancer Care,Genetic Disorders,Hematologic Diseases,Cancer,Immune System Diseases
|
Lisa Gennarini, MD
|
Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]
|
Lung Cancer
|
Steven Keller, MD
|
Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant Recipients
|
Kidney Diseases (incl Chronic Kidney Disease),Nephrology,Urologic Diseases
|
Enver Akalin, MD
|
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
|
Medical and Hematologic Oncology
|
Balazs Halmos, MD
|
Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis
|
|
Dana Lukin, MD
|
TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer
|
Breast Cancer,Neoplasms
|
Jana Fox, MD
|
Targeted Intra-arterial Gemcitabine vs. Continuation of IV Gemcitabine Plus Nab-Paclitaxel Following Induction With Sequential IV Gemcitabine Plus Nab-Paclitaxel and Radiotherapy for Locally Advanced Pancreatic Cancer (TIGeR-PaC)
|
Pancreatic Cancer,Surgery,Endocrinology,Neoplasms
|
Peter Muscarella, MD
|
Technology-Assisted Weight Management Intervention Within Patient-Centered Medical Homes: The GEM (Goals for Eating and Moving) Study
|
Overweight, Obesity and Weight Loss
|
Judith Wylie-Rosett, MD
|
Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
|
Brain Cancer
|
Mary Welch, MD
|
Testing Decision Aids to Improve Prostate Cancer Decisions for Minority Men (Alliance A191402CD)
|
Prostate Cancer,Urologic Oncology (Med Onc),Urologic Diseases,Cancer,Neoplasms
|
Evan Kovac, MD
|
The ASTHMA-Educator: A novel Algorithmic Software Tool in the Healthcare system for Managing Asthma
|
Asthma and other Respiratory Diseases
|
Sunit P. Jariwala, MD
|
The Children’s Spine Registry
|
Bones, Muscles & Joints (Orthopaedics)
|
Jaime Gomez, MD
|
The Chimerix CMX001 Registry
|
Blood and Bone Marrow Cancer
|
Olga Derman, MD
|
The Comparison Study of Virtual Reality Rehabilitation With Standard Occupational Therapy Versus Standard Occupational Therapy
|
Heart and Vascular Diseases,Rehabilitation Medicine,Stroke and Cerebrovascular Diseases
|
Gary Inwald, MD
|
The Effect of AposTherapy on Pain and Function in a Non Specific Low Back Pain Population. A Randomized Controlled Trial
|
Rehabilitation Medicine,Nervous System Diseases
|
Matthew Bartels, MD
|
The Effect of AposTherapy on Pain and Function in Knee Osteoarthritis Population: A Randomized Controlled Trial
|
Osteoarthritis,Rehabilitation Medicine,Arthritis,Musculoskeletal Diseases
|
Matthew Bartels, MD
|
The Effect of Footwear Generated Biomechanical Manipulation on Symptoms of Stress Urinary Incontinence: A Randomized Controlled Trial
|
Mental Health and Disorders,Urinary Disorders,Urologic Diseases,Rehabilitation Medicine
|
Anna Lasak, MD
|
The Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma and/or DCIS in Patients Diagnosed With Intraductal Papilloma Without Atypia or Flat Epithelial Atypia by Core Needle Biopsy
|
Cancer,Carcinoma,Neoplasms
|
Rouzan Karabakhtsian, MD
|
The Influence of Breakfast on Hormone Responses and Cognitive Performance, as Assessed by CTET in Lean and Obese Adolescent Males
|
Overweight, Obesity and Weight Loss,Pediatric Endocrinology,Metabolic Diseases
|
Lisa Underland, MD
|
The National Emergency Airway Registry for Children
|
Asthma and other Respiratory Diseases
|
Michael Miksa, MD
|
The National Myelodysplastic Syndromes Natural History Study
|
Blood Disorders and Diseases,Myelodysplastic Syndrome (MDS),Hematologic Diseases,Medical and Hematologic Oncology,Oncology (Medical/Hematologic),Cancer,Neoplasms
|
Aditi Shastri, MD
|
The OPTIMIZE Trial to Assess the Procedural and Clinical Value of the Svelte IDS and RX Sirolimus Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions in a Randomized Study (OPTIMIZE)
|
Heart and Vascular Diseases,Cardiology
|
Giora Weisz, MD
|
The Reliability of X-Ray Based Evaluation of Pedicle Screw Misplacement in Adolescent Spinal Deformity
|
Bones, Muscles & Joints (Orthopaedics)
|
Vishal Sarwahi, MD
|
The Role of Hemolysis in Promoting Thrombosis During Mechanical Circulatory Support With Continuous Flow Pumps
|
Heart and Vascular Diseases,Cardiology,General Internal Medicine,Embolism or Thrombosis,Heart Failure
|
Omar Saeed, MD
|
The Role of Hepatic Denervation in the Dysregulation of Glucose Metabolism in Liver Transplant Recipients
|
Diabetes and Endocrine,Liver Diseases,Endocrinology,Metabolic Diseases
|
Meredith Hawkins, MD
|
The Selective Personalized Radio-Immunotherapy for Locally Advanced NSCLC Trial (SPRINT)
|
Lung Cancer,Neurology,Radiation Oncology,Carcinoma,Neoplasms
|
Nitin Ohri, MD
|
The use of Complementary and Alternative Medicine in Autism
|
Autism Spectrum Disorder
|
Maria Valicenti-McDermott, MD
|
The Use of Lumbar Erector Spinae Plane Block for Hip Arthroplasty at the L4 Interspace- a Randomized Controlled Study Comparing the 24-hour Opioid Requirements
|
Anesthesia and Pain Management,Anesthesiology,Musculoskeletal Diseases
|
Iyabo Muse, MD
|
The use of Virtual Reality Games to Enhance Therapy for Children with Cerebral Palsy. A pilot Study
|
Brain and Neurological
|
Maria Valicenti-McDermott, MD
|
Therasphere for Unresectable Primary or Secondary Liver Neoplasia
|
Oncology (Medical/Hematologic)
|
Renee Moadel, MD
|
TMEM-MRI: A Pilot Feasibility Study of Magnetic Resonance Imaging for Imaging of TMEM (Tumor Microenvironment of Metastasis) in Patients With Operable Breast Cancer
|
Breast Cancer,Skin Disorders,Neoplasms
|
Jesus Anampa Mesias, MD
|
Tolerization Reduces Intolerance to Pegloticase and Prolongs the Urate Lowering Effect (TRIPLE)
|
Orthopaedic Surgery
|
John Hardin
|
Tomosynthesis Mammographic Imaging Screening Trial (TMIST)
|
Breast Cancer,Women`s Health,Oncology (Medical/Hematologic),Radiation Oncology
|
Beatriu Reig, MD
|
Topical or Ablative Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Squamous Intraepithelial Lesions (ANCHOR)
|
HIV/AIDS,Anal Cancer
|
Rebecca Levine, MD
|
Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer
|
Head and Neck Cancer
|
Missak Haigentz, MD
|
Transthyretin-Associated Amyloidosis Outcomes Survey (THAOS) A Global, Multi-Center, Longitudinal, Observational Survey of Patients With Documented Transthyretin (TTR) Mutations or Wild-Type TTR Amyloidosis
|
Cardiology,Amyloidosis,Neuromuscular Diseases
|
James Tauras, MD
|
Treatment of Breast Fibroadenoma Targeted Tissue With High Intensity Focused Ultrasound (HIFU)
|
Women`s Health,Surgery,Family and Social Medicine,Fibroadenoma,Neoplasms
|
Sheldon Feldman, MD
|
Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents
|
Pediatric Hematology/Oncology,Leukemia,Lymphatic and Spleen Diseases,Neoplasms,Lymphoproliferative Disorders
|
Lisa Gennarini, MD
|
US-based, Observational, Drug Registry of Opsumit® (Macitentan) New Users in Clinical Practice
|
Heart and Vascular Diseases
|
Sandhya Murthy, MD
|
Use of Functional MRI to Assess Functional Hypothalamic Activation in Response to Diazoxide
|
Diabetes and Endocrine,Endocrinology,Metabolic Diseases
|
Meredith Hawkins, MD
|
Use of Perioperative Antibiotics in Endoscopic Sinus Surgery
|
Asthma and other Respiratory Diseases,Ears, Nose and Throat
|
Nadeem Akbar, MD
|
VALENS: A Ph 1/2, Random'd, Open-Label, Ascending-Dose, Delayed-Treatment Concurrent Control Clinical Study to Evaluate Safety/Preliminary Efficacy of AT342, an AAV8-Delivered Gene Transfer Therapy in Crigler-Najjar Syndrome Subjects Aged 1 Yr and Older
|
Heart and Vascular Diseases,Brain and Neurological,Gastroenterology & Liver Diseases,Pediatrics,Crigler-Najjar Syndrome,Metabolic Diseases
|
Nadia Ovchinsky, MD
|
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
|
Solid Tumor
|
Sanjay Goel, MD
|
Web-based Peer Mentor Training to Reduce Hospitalizations for Children with Asthma
|
Asthma and other Respiratory Diseases,Pediatrics,Lung Diseases
|
Deepa Rastogi, MD
|
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
|
Lung Cancer
|
William Bodner, MD
|